Scientific article
OA Policy
English

Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study

Published in

PloS one, vol. 17, no. 11, e0277653

Publication date

2022-11-23

First online date

2022-11-23

Abstract

Aims: To assess the associations of exposure and modifications in exposure (i.e., discontinuation on admission, initiation during hospitalization) to eight common cardiovascular therapies with the risk of in-hospital death among inpatients with coronavirus disease 2019 (COVID-19).

Methods: In this observational study including 838 hospitalized unvaccinated adult patients with confirmed COVID-19, the use of cardiovascular therapies was assessed using logistic regression models adjusted for potential confounders.

Results: No cardiovascular therapy used before hospitalization was associated with an increased risk of in-hospital death. During hospitalization, the use of diuretics (aOR 2.59 [1.68-3.98]) was associated with an increase, and the use of agents acting on the renin-angiotensin system (aOR 0.39 [0.23-0.64]) and lipid-lowering agents (aOR 0.41 [0.24-0.68]) was associated with a reduction in the odds of in-hospital death. Exposure modifications associated with decreased survival were the discontinuation of an agent acting on the renin-angiotensin system (aOR 4.42 [2.08-9.37]), a β-blocker (aOR 5.44 [1.16-25.46]), a lipid-modifying agent (aOR 3.26 [1.42-7.50]) or an anticoagulant (aOR 5.85 [1.25-27.27]), as well as the initiation of a diuretic (aOR 5.19 [2.98-9.03]) or an antiarrhythmic (aOR 6.62 [2.07-21.15]). Exposure modification associated with improved survival was the initiation of an agent acting on the renin-angiotensin system (aOR 0.17 [0.03-0.82]).

Conclusion: In hospitalized and unvaccinated patients with COVID-19, there was no detrimental association of the prehospital use of any regular cardiovascular medication with in-hospital death, and these therapies should be continued as recommended.

Keywords

  • Adult
  • COVID-19 Drug Treatment
  • Cohort Studies
  • Diuretics / therapeutic use
  • Hospital Mortality
  • Hospitalization
  • Humans
  • Lipids

Citation (ISO format)

FOLLONIER, Cédric Vincent et al. Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study. In: PloS one, 2022, vol. 17, n° 11, p. e0277653. doi: 10.1371/journal.pone.0277653

Main files (1)

Article (Published version)

Secondary files (9)

Appendix - Additional definitions.
Supplemental data - S1 Table
Supplemental data - S2 Table
Show more

Identifiers

Additional URL for this publication

https://dx.plos.org/10.1371/journal.pone.0277653

Journal ISSN

1932-6203
112views
174downloads

Technical informations

Creation

28/11/2022 17:52:40

First validation

01/06/2023 10:19:08

Update

21/01/2025 15:52:15

Status update

21/01/2025 15:52:15

Last indexation

21/01/2025 16:00:47
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated